Ignyta Sets Chief Business Officer

San Diego-based Ignyta, a developer of oncology biotechnology products, said today that it has named William McCarthy as its new Chief Business Officer. McCarthy was most recently Vice President, Corporate and Business Development at Foundation Medicine (FMI), and also has served at Halozyme Therapeutics, Biogen Idec, Neurocrine Biosciences, IMS Consulting Group, Deloitte Consulting, and Cambridge Pharma Consultancy.